APPLICATIONS PUBLISHED 2 MAY 2003
Published: 1-Oct-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Embolisation using carbon-coated particles
Carbon Medical Technologies 1305004*
Microemulsion and micelle system for solubilising drugs
University of Florida 1305005*
Dispersions for formulating slightly or poorly soluble active ingredients
Pharmasol 1305006*
Pharmaceutical compsns of cholesteryl ester transfer proteins
Pfizer Products 1305007*
Improved forms of pharmaceutically active agents and method for manufacture thereof
RP Scherer Technologies 1305008*
Cross-linked high amyloe starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
Lanaerts, Vincent; Beck, Rowland Herwig Friedrich; Bogaert, Elsie van; Chouinard, Francois; Hopcke, Reiner; Desevaux, Cyril 1305009*
Dosage forms for treatment of oral mycoses
Knoll 1305010*
Compsns and films for capsule manufacture
Union Carbide Chemicals & Plastics Technology Corp 1305011*
A method for treating coeliac disease
Sigma-Tau Industrie Farmaceutische Riunite 1305012*
Preparation with vascular protective and anti-oxidative effect and use thereof
Steigerwald Arzneimittelwerk 1305013*
Method for the treatment of climacteric disorders in women during or after the menopause
Hormos Medical Corp 1305014*
Substituted styryl benzylsulphones for treating proliferative disorders
Temple University of the Commonwealth System of Higher Education 1305015*
Use of N-oleoylethanolamine for treating psoriasis
Krutmann, Jean; Grether-Beck, Susanne 1305016*
Methods and compsns for the prevention and treatment of syndrome X
Pharmanutrients 1305017*
Method and compsns for prevention and/or treatment of diabetes and glucose modulation
Pharmanutrients 1305018*
Immunomodulatory compounds
The University of Maryland at Baltimore 1305019*
Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
Sigma-Tau Industrie Farmaceutische Riunite 1305020*
Rapidly expanding compsn for gastric retention and controlled release of therapeutic agents, and dosage forms including the compsn
Teva Pharmaceutical Industries 1305021*
Processes for the purification of tocopherol and/or sterol compounds and compsns containing orthoborate ester mixtures
Cognis 1305022*
Use of selective adenosine A1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis
University of Virginia Patent Foundation 1305023*
Method for treating fibrotic diseases of other indications
Alteon 1305024*
Pharmaceutical compsn comprising metformin and a 5-phenoxylakyl-2,4-thiazolidinedione-type derivative
Merck 1305025*
Barbituric acid analogues as therapeutic agents
Novuspharma 1305026*
Use of an aldehyde-5-oxo-1,2,4-triazine hydrazide for the treatment of cancer
Procter & Gamble 1305027*
Antimicrobial biaryl compounds
Isis Pharmaceuticals 1305028*
Method of increasing sensitivity of mammography
The Cleveland Clinic Foundation 1305029*
Use of 2(a)-methyl-19-nor-20(S)-1(a),25-dihydroxyvitamin D3 to increase bone strength
Wisconsin Alumni Research Foundation 1305030*
Combination preparations of 3-N-formylhydroxyaminopropylphosphonic acid derivatives or 3-N-acetylhydroxyaminopropylphosphonic acid derivatives combined with specific pharmaceutical active agents
Jomaa Pharmaka 1305031*
Compsns and methods of preventing or reducing the risk or incidence of skeltal injuries in horses
Merck 1305032*
Pharmaceutical compsns containing tobramycin and xanthan gum
Alcon 1304033*
Methods of producing weight loss and treatment of obesity
Kozachuk, Walter E 1305034*
NAADP analogues for modulating T-cell activity
University of Bath 1305035*
Nutritional compsn
Societe des Produits Nestle 1305036*
Anti-inflammatory medicament
Universita' Degli Studi di Milano 1305037*
Bacteriophage having multiple host range
The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services 1305038*
Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
Georgetown University 1305039*
Transplant media
Murphy, Christopher 1305040*
Medicament for the immunotherapy of malignant tumours
Liponova 1305041*
Compsns and methods for treatment of mucosal infections
Pneumobiotics 1305042*
Respiratory syncytial virus vaccine
Aventis Pasteur 1305043*
QS-21 and IL-12 as an adjuvant combination
Wyeth Holdings 1305044*
Treatment of B-cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
Idec Pharmaceuticals 1305045*
Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance
Bristol-Myers Squibb 1305046*
Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
Schering 1305047*
Inhibitors of cellular efflux pumps of microbes
Wockhardt 1305048*
Methods of treating burns on mammalian skin to reduce the risk of infection and to minimise fluid loss
Flowers Park 1305049*
